Archana Tamoshunas, Partner

T: 212.931.0704 | E:

Archana Tamoshunas focuses her practice on complex class action litigation, including antitrust and consumer protection litigation. Over her career, Ms. Tamoshunas has been counsel in numerous complex federal antitrust class actions and specializes in those involving the pharmaceutical and medical device industries. She is active in all aspects of the litigation process including day-to-day management of discovery, briefing, class certification and trial preparation. Ms. Tamoshunas currently represents purchasers of prescription drugs in federal antitrust actions alleging that pharmaceutical manufacturers have wrongfully prevented or delayed less expensive generic drugs from entering the market in several class actions including, In re Zetia (Ezetimibe) Antitrust Litigation (Executive Committee) (E.D.Va.); In re Niaspan Antitrust Litigation (E.D. Pa.); In re Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (E.D. Pa.); In re Bystolic Antitrust Litigation (S.D.N.Y.); and In re Seroquel XR (Extended Release Quetiapine Fumarate) Antitrust Litigation (D. Del.).

Ms. Tamoshunas has also represented direct purchasers in antitrust cases that have been successfully resolved including In re Lidoderm Antitrust Litigation (N.D. Cal.), in which her firm was appointed to the Executive Committee and she was personally involved in management and trial preparation of the case ($166 million settlement); In re Solodyn Antitrust Litigation (D. Mass.) ($72.5 million settlement); In re Skelaxin (Metaxalone) Antitrust Litigation (E.D. Tenn.) ($73 million settlement), In re Prandin Direct Purchaser Antitrust Litigation (E.D. Mich.) (Executive Committee) ($19 million settlement) and Mylan Pharmaceuticals v. Warner Chilcott (E.D. Pa.) ($15 million settlement), and was heavily involved in the management of successfully resolved cases including In re Relafen Antitrust Litigation (D. Mass.); In re Terazosin Hydrochloride Antitrust Litigation (S.D. Fla.) and Natchitoches Parish Hospital District et al. v. Tyco International, et al. (D. Mass.).

Ms. Tamoshunas graduated from Williams College (B.A.) and from New York University School of Law, where she was a member of the Moot Court Board and had her case problem published in the New York University School of Law Moot Court Casebook (Vol. 22, 1998). After graduating from law school, Ms. Tamoshunas represented the City of New York in child abuse and neglect cases in Family Court.

Ms. Tamoshunas is admitted to the Bar of the State of New York as well as the Southern and Eastern Districts of New York, the Eastern District of Michigan and the First Circuit Court of Appeals. She is a member of the Antitrust Law Section of the New York State Bar Association.

Scroll to Top